Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Shockwave Medical Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

Microsoft Excel
Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents 281,674 328,422 498,108 141,458 280,932 156,586 127,779 99,913 66,252 89,209 91,195 84,268 57,006 50,423 215,256 218,296 123,111 139,045 39,452 41,924 138,064
Short-term investments 747,559 662,132 419,225 117,131 135,929 147,907 122,888 124,993 134,875 111,772 91,759 90,478 120,422 151,931 13,109 47,278 56,304 74,646 83,213
Accounts receivable, net 124,440 114,552 98,819 96,562 84,309 71,366 64,224 59,797 47,842 37,435 29,966 24,955 19,613 11,689 10,711 6,365 7,811 7,377 5,551 5,242 3,939
Inventory 111,215 107,587 97,180 92,093 83,256 75,112 68,974 60,028 53,369 42,978 38,744 36,149 33,538 29,859 28,868 23,427 15,921 12,074 9,227 8,291 7,014
Prepaid expenses and other current assets 10,462 12,567 15,210 9,118 6,399 8,292 11,393 7,275 7,572 4,508 4,364 3,781 2,533 2,398 3,033 3,117 3,485 1,897 2,199 1,953 2,508
Current assets 1,275,350 1,225,260 1,128,542 456,362 590,825 459,263 395,258 352,006 309,910 285,902 256,028 239,631 233,112 246,300 257,868 264,314 197,606 216,697 131,075 140,623 151,525
Operating lease right-of-use assets 34,919 29,707 30,360 31,117 31,623 32,365 33,107 26,045 26,729 27,496 11,790 6,825 7,211 7,568 7,841 8,130 8,495 8,825 2,155 2,398 2,645
Property and equipment, net 78,693 68,923 62,017 59,803 54,057 48,152 39,265 32,253 27,886 24,361 23,085 21,467 20,233 16,362 13,282 13,287 13,084 4,910 4,111 3,244 2,803
Equity method investment 2,356 1,643 1,810 2,543 2,689 3,512 4,573 4,476 5,940 5,987 6,408 6,750 6,750
Intangible assets, net 91,960 92,857 93,775 94,692
Goodwill 39,568 39,568 39,789 39,789
Deferred tax assets 111,900 99,169 109,432 94,699 97,941 97,568
Other assets 9,001 9,436 8,234 7,599 6,112 5,229 3,606 2,365 2,055 1,936 1,684 1,686 1,764 1,812 1,667 1,622 1,553 1,506 548 542 566
Noncurrent assets 368,397 341,303 345,417 330,242 192,422 186,826 80,551 65,139 62,610 59,780 42,967 36,728 35,958 25,742 22,790 23,039 23,132 15,241 6,814 6,184 6,014
Total assets 1,643,747 1,566,563 1,473,959 786,604 783,247 646,089 475,809 417,145 372,520 345,682 298,995 276,359 269,070 272,042 280,658 287,353 220,738 231,938 137,889 146,807 157,539

Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Shockwave Medical Inc. current assets increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Shockwave Medical Inc. property and equipment, net increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Shockwave Medical Inc. noncurrent assets decreased from Q3 2023 to Q4 2023 but then increased from Q4 2023 to Q1 2024 exceeding Q3 2023 level.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Shockwave Medical Inc. total assets increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Shockwave Medical Inc. cash and cash equivalents decreased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Short-term investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. Shockwave Medical Inc. short-term investments increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Accounts receivable, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Shockwave Medical Inc. accounts receivable, net increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Inventory Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Shockwave Medical Inc. inventory increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.